Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective studyWei-Li Xia, Hai-Liang Li, Weijun Fan et al.|Frontiers in Oncology|2022Cited by 25
Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective StudyWei-Li Xia, Hai-Liang Li, Xiao-Hui Zhao et al.|Clinical and Translational Gastroenterology|2023Cited by 15
Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinomaYuan Guo, Hai-Liang Li, Ru-Chun Li et al.|World Journal of Gastrointestinal Oncology|2024Cited by 11
Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinomaWei-Li Xia, Hai-Liang Li, Shi‐Jun Xu et al.|Frontiers in Oncology|2022Cited by 5
TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal ShuntsWei-Li Xia, Hai-Liang Li, Xiao-Hui Zhao et al.|Journal of Hepatocellular Carcinoma|2024Cited by 2